A Kaplan-Meier analysis also demonstrated a positive correlation between TTYH1 expression and life expectancy in triple-negative breast cancer patients, conferring TTYH1 as a potential disease biomarker and suggesting that TTYH1 may hinder breast cancer progression (Zhong et al., 2020). This evidence concerns the gene TTYH1 and triple-negative breast carcinoma.